PGY-2 Medication Use Safety

Share
Print
Share
Print

Memorial Sloan Kettering (MSK) is pleased to offer a 12-month post graduate training program that provides advanced training in medication-use safety, quality assessment, and drug policy. The program offers a diverse experience designed to develop the resident’s skill in medication safety principles, leadership, process improvement, institutional policy development, planning, and research.

The resident will be prepared to assume a leadership position to implement sustained medication-use and quality improvement strategies in adult and pediatric patients. The resident will use our fully integrated electronic medical record with over 6000 order sets and a library of comprehensive drug guidelines for virtually all medications that are used in patients with cancer. The resident will also utilize our robust electronic reporting system to dissect actual events and trend improvement efforts that enhance the care of our patients. The resident will interact with our experienced pharmacy staff that operates in one of the most comprehensive and decentralized pharmacy systems in the country including a large team of clinical pharmacy specialists. The resident will also learn about the medication use challenges in one of the biggest investigational drug programs in the world with an NCI- supported research pharmacy. The resident will attend several interdisciplinary institutional committees including Pharmacy and Therapeutics, Pharmacy Quality Assessment, and Medication Management. The resident will learn how to be a confident presenter by delivering monthly didactic presentations including medication safety pearls, journal clubs, and pharmacy grand rounds programs.

Required Rotations

Educational rotations will include:

  • Comprehensive Orientation Program to All Systems
  • Medication Safety Leadership [longitudinal]: Joint Commission Medication Management Standards, ISMP/IHI guidelines, Evaluating the Literature, Just Culture, Root Cause Analysis
  • Pharmacy Operations [longitudinal]: Focus on Technology and Standardizing the Medication-use system
  • Drug Policy [longitudinal]: Formulary Management, Therapeutic Guidelines, National Patient Safety Goals, Regulatory Readiness, Drug Shortages, and FDA mandates
  • Medication Event Analysis [longitudinal]: Dissect and trend actual and close-call events; appropriate application of health information technology including clinical decision support, automation system, and smart infusion pumps.
  • Investigational Drug Service [longitudinal]
  • Clinical Rotations with Pharmacy Specialists/Clinical Coordinators in Geriatrics, Pediatrics, Oncology Practice, Adult Critical Care, Transitions of Care, and Pain Management
  • Research Project with explicit goal of publication in a peer-reviewed publication

Application Deadline

January 15, 2020

Length of Program

One year

Number of Positions

One

Eligibility

  • Successful completion of an ACPE accredited Doctor of Pharmacy program
  • Successful completion of an ASHP accredited PGY-1 Pharmacy Practice Residency
  • Eligibility for pharmacist licensure in New York State (Residents are required to obtain Pharmacist licensure in the State of New York by October 1, 2020)

How to Apply

Interested candidates should submit the following through Pharmacy Online Residency Centralized Application (PhORCAS):

  • Letter of interest explaining career goals
  • Three letters of recommendation (standard PHORCAS format)
  • Academic transcript
  • Curriculum Vitae

Additional Information

Frequently Asked Questions
Residency Program Preceptors
Residency Learning Experiences and Teaching Activities

Contact

Raymond Muller, MS, RPh, FASHP
Director, Drug Policy Management, Quality, Safety, Training and Education
Medication Use Safety and Policy PGY-2 Residency Program Director
Memorial Sloan Kettering Cancer Center
1114 First Avenue, Room 618
New York, NY 10065
[email protected]
646-888-0979